Skip to main content
. 2021 Apr 30;31(11):8208–8217. doi: 10.1007/s00330-021-07970-2

Table 3.

Patient characteristics of the NPSLE patients with an inflammatory phenotype and the NPSLE patients with an ischemic phenotype

NPSLE inflammatory (n = 26) NPSLE ischemic (n = 12) p value
Female, n (%) 23 (89%) 10 (83%) 0.664
Age, years 39 ± 15 41 ± 11 0.581
Hypertension 11 (42%) 5 (42%) 0.970
Current smoking 3 (12%) 2 (17%) 0.666
BMI 24 ± 5 26 ± 5 0.274
Diabetes 1 (3%) 2 (15%) 0.154
Duration of SLE 4 ± 6 10 ± 10 0.012*
SLEDAI-2K 10 ± 9 4 ± 3 0.030*
SDI 1.0 ± 1.1 1.3 ± 1.0 0.185

Data represents n (percentage) or means ± standard deviations. Gender, age, cardiovascular risk factors, duration of disease, and damage indexes are shown. Differences between the two groups are expressed in p value and calculate for nominal variables with chi-square (gender, hypertension, smoking, and diabetes) and for continuous variables with an unpaired t-test (age and BMI) or Mann-Whitney U test (duration of SLE, SLEDAI-2K, and SDI) based on their distribution

BMI body mass index, SLEDAI-2K Systemic Lupus Erythematosus Disease Activity Index 2000, SDI Systemic Lupus International Collaborating Clinics Damage Index

*p < 0.05